£595.00

The 2016-2021 Outlook for Generic Prescription Drugs in Japan

Econometrics

Price data last checked 13 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 78 days · 78 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 78 days • 1 price levels

Days at Price

Price Analysis

Most common price: £595 (78 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 78 days

Description

This econometric study covers the latent demand outlook for generic prescription drugs across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 1,000 cities in Japan. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for generic prescription drugs. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the cities in Japan). This study gives, however, my estimates for the latent demand, or the P.I.E., for generic prescription drugs in Japan. It also shows how the P.I.E. is divided and concentrated across the cities and regional markets of Japan.

Product Specifications

Format: paperback
ASIN: B01N7DTOX1
Category: Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain: Amazon UK
Release Date: 22 September 2015
Listed Since: 02 December 2016

The 2016-2021 Outlook for Generic Prescription Drugs in Japan

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2016-2021 Outlook for Generic Prescription Drugs in Greater China

The 2016-2021 Outlook for Generic Prescription Drugs in the United States

The 2025-2030 World Outlook for Generic Prescription Drugs

The 2016-2021 Outlook for Drug Stores and Pharmacies in Japan

The 2023-2028 Outlook for Drug Stores and Proprietary Stores in the United States

The 2016-2021 Outlook for Online Health and Pharmacy-Related Products in Japan

The 2023-2028 Outlook for Drugstores in India

The 2023-2028 Outlook for Drugstores in the United States

The 2023-2028 Outlook for Over the Counter Drugs in India

The 2023-2028 Outlook for Pharmacies and Drug Stores in the United States

The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense Organs in Japan

The 2016-2021 Outlook for Synthetic Organic Medicinal Chemicals, Medicinal and Botanical Drugs and Chemicals in Bulk, Alkaloid Drugs, and Naturally Occurring Vitamins in Japan

The 2016-2021 Outlook for Pharmaceutical Preparations Affecting the Central Nervous System and Sense Organs in Japan

The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Affecting Neoplasms, the Endocrine System, and Metabolic Diseases in Japan

The 2013-2018 Outlook for Generic Drugs in India

The 2016-2021 Outlook for Over-The-Counter Health Care Products in Japan

The 2021-2026 World Outlook for Pharmacies and Drug Stores

The 2023-2028 Outlook for Drugstores in Japan

The 2016-2021 Outlook for OTC Healthcare Products in Japan

The 2016-2021 Outlook for Physicians' Services in Japan

The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Acting on the Central Nervous System and the Sense Organs in Greater China

The 2016-2021 Outlook for Prepackaged Medical Kits and Trays in Japan

The 2023-2028 Outlook for OTC Drugs in India

The 2021-2026 World Outlook for Direct-to-Consumer (DTC) Pharmaceutical Advertising